Webside score cancerresearchhorizons.com
Cancer Research Horizons
Genereret April 02 2026 07:09 AM
Gammel data? OPDATER !
Scoren er 66/100
SEO Indhold
Titel
Cancer Research Horizons
Længde : 24
Perfekt, din titel indeholder mellem 10 og 70 bogstaver.
Beskrivelse
We are a specialist drug discovery, development and commercialisation company, taking cutting edge innovations from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients.
Længde : 225
Kan optimeres; din meta beskrivelse bør indeholde mellem 70 og 160 karakterer (med mellemrum). Brug dette gratis redskab til at regne længden ud.
Nøgleord
Dårligt! Vi kan ikke finde nogle meta nøgleord på din side! Brug denne gratis online meta generator for at oprette nye nøgleord.
Og Meta Egenskaber
Godt, din side benytter Og egenskaberne
| Egenskab | Indhold |
|---|---|
| site_name | Cancer Research Horizons |
| url | https://www.cancerresearchhorizons.com/home-page |
| title | Home page |
| description | We are a specialist drug discovery, development and commercialisation company, taking cutting edge innovations from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients. |
| image | https://www.cancerresearchhorizons.com/sites/default/files/styles/uncropped_large/public/2024-08/2023.05.22_CancerResearchHorizons_0285.jpg?itok=Gh4yhTOU |
Overskrifter
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 8 | 19 | 0 | 0 | 0 |
- [H1] Our business is breakthroughs
- [H2] Main navigation
- [H2] Innovate and work with us
- [H2] Latest news
- [H2] Our portfolio
- [H2] Connect with us
- [H2] Social links
- [H2] Key links
- [H2] Address
- [H3] 14
- [H3] £600m+
- [H3] 150+
- [H3] 90+
- [H3] £3.45bn+
- [H3] Researchers
- [H3] Partners
- [H3] Investors
- [H3] C-Further unveils first therapeutic programmes dedicated to paediatric oncology
- [H3] In search of the missing link
- [H3] The cutting-edge of translational oncology - directly to your inbox
- [H3] Cancer Research UK and NovalGen dose the first patient in the Phase 1 trial of T-cell engager NVG-222
- [H3] Laigo Bio completes final close of oversubscribed seed financing of €17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs
- [H3] C-Further unveils first therapeutic programmes dedicated to paediatric oncology
- [H3] Artios receives US FDA Fast Track Designation for DNA polymerase theta (Polθ) inhibitor ART6043 for treatment of gBRCA-mutated HER2-negative breast cancer
- [H3] Drug discovery and development capabilities
- [H3] Explore our pipeline
- [H3] Licensing opportunities
- [H3] Our start-up portfolio
Billeder
Vi fandt 31 billeder på denne side.
Godt, de fleste eller alle af dine billeder har ALT tags.
Text/HTML balance
Balance : 16%
Godt, denne side har en god fordeling af text og HTML. Balancen er højere end 15, men lavere end 25 procent.
Flash
Perfekt, ingen Flash objekter er blevet fundet på siden.
iFrame
Beklager! Din side har iFrames og det kan medføre i yderst dårlig læsning af søgerobotterne.
SEO Links
URL Omskrivning
Godt. Dine links ser venlige ud!
Underscores i links
Perfekt! Ingen underscores blev fundet i dine links
On-page links
Vi fandt et total af 48 links inkluderende 0 link(s) til filer
| Anker | Type | Juice |
|---|---|---|
| Our people | Intern | Sender Juice |
| Our boards | Intern | Sender Juice |
| Our impact | Intern | Sender Juice |
| Our reports and corporate responsibility | Intern | Sender Juice |
| Our expert network | Intern | Sender Juice |
| Careers | Intern | Sender Juice |
| Protect your innovation | Intern | Sender Juice |
| Entrepreneurial training | Intern | Sender Juice |
| Access funding | Intern | Sender Juice |
| Set up and build your start-up | Intern | Sender Juice |
| Translational science | Intern | Sender Juice |
| Our community | Intern | Sender Juice |
| Our partnerships | Intern | Sender Juice |
| Our start-up portfolio | Intern | Sender Juice |
| Our pipeline | Intern | Sender Juice |
| Licensing opportunities | Intern | Sender Juice |
| Access multi-modal cancer datasets | Intern | Sender Juice |
| Medtech and diagnostics | Intern | Sender Juice |
| Our Seed Fund | Intern | Sender Juice |
| Donating to the Cancer Impact Booster | Intern | Sender Juice |
| Our drug discovery science | Intern | Sender Juice |
| Functional Genomics Centre | Intern | Sender Juice |
| Centre for Drug Development | Intern | Sender Juice |
| Research tools | Intern | Sender Juice |
| Our data portfolio | Intern | Sender Juice |
| Our success stories | Intern | Sender Juice |
| Our news | Intern | Sender Juice |
| Our articles | Intern | Sender Juice |
| Our media | Intern | Sender Juice |
| Events | Intern | Sender Juice |
| Find out more | Intern | Sender Juice |
| Learn more | Intern | Sender Juice |
| Learn more | Intern | Sender Juice |
| Subscribe here | Ekstern | Sender Juice |
| Subscribe to our newsletter | Ekstern | Sender Juice |
| Researchers | Intern | Sender Juice |
| Partners | Intern | Sender Juice |
| Investors | Intern | Sender Juice |
| Portfolio | Intern | Sender Juice |
| News and events | Intern | Sender Juice |
| Contact us | Intern | Sender Juice |
| Terms and conditions | Intern | Sender Juice |
| Privacy policy | Intern | Sender Juice |
| Modern slavery statement | Intern | Sender Juice |
| Section 172 | Intern | Sender Juice |
| Legal status | Intern | Sender Juice |
| Cookie policy | Intern | Sender Juice |
| Full disclosure of interactions with industry | Ekstern | Sender Juice |
SEO Nøgleord
Nøgleords cloud
drug partners start-up research development portfolio science translational news cancer
Nøgleords balance
| Nøgleord | Indhold | Titel | Nøgleord | Beskrivelse | Overskrifter |
|---|---|---|---|---|---|
| portfolio | 18 |  |
|
|
 |
| cancer | 15 | |
|
|
|
| start-up | 11 | |
|
|
|
| research | 9 | |
|
|
|
| science | 9 | |
|
|
|
Brugervenlighed
Link
Domæne : cancerresearchhorizons.com
Længde : 26
FavIkon
Godt, din side har et FavIcon!
Printervenlighed
Vi kunne ikke finde en printer venlig CSS skabelon.
Sprog
Godt, dit tildelte sprog er en.
Dublin Core
Denne side benytter IKKE Dublin Core principperne.
Dokument
Dokumenttype
HTML 5
Kryptering
Perfekt. Dit Charset er tildelt UTF-8.
W3C Validering
Fejl : 0
Advarsler : 0
Email Privatliv
Godt! Ingen email adresser er blevet fundet i rå tekst!
Udgået HTML
Godt! Vi har ikke fundet udgåede HTML tags i din kildekode
Hastigheds Tips
|
Alle tiders! Din webside bruger ikke nestede tabeller. |
|
Advarsel! Din webside benytter inline CSS kode! |
|
Godt, din website har få antal CSS filer |
|
Perfekt, din website har få JavaScript filer. |
|
Perfekt, din hjemmeside udnytter gzip. |
Mobil
Mobil Optimering
|
Apple Ikon |
|
Meta Viewport Tag |
|
Flash indhold |
Optimering
XML Sitemap
Stor, din hjemmeside har en XML sitemap.
| https://www.cancerresearchhorizons.com/sitemap.xml |
Robots.txt
https://cancerresearchhorizons.com/robots.txt
Stor, din hjemmeside har en robots.txt-fil.
Analytics
Mangler
Vi har ikke registrerer en analyseværktøj installeret på denne hjemmeside.
Web analytics kan du måle besøgendes aktivitet på dit websted. Du bør have mindst én analyseværktøj installeret, men det kan også være godt at installere et sekund for at krydstjekke data.
PageSpeed Insights
Apparat
Kategorier
Free SEO Testing Tool
Free SEO Testing Tool er et gratis SEO redskab der hjælper med din hjemmeside